Dan is a founding member and partner of NeuroVentures, a specialty venture capital firm, established in 2000 to invest in emerging biopharmaceutical and medical technology companies committed to developing better treatments for Central Nervous System diseases. Currently, he represents NeuroVentures on the board of Setagon and is an observer with Acumen Pharmaceuticals, Concentric Medical and Rivanna Pharmaceuticals. He was previously a board observer to Cyberkinetics Neurotechnology Systems (CYKN.OB).  Dan’s experience with neurological-related medical technology companies includes co-founding MedSpecialists, Inc., a venture-backed clinical applications service provider, and Surgical Solutions, LLC, a company which developed neurosurgical products licensed from leading research institutions.

Prior to attending business school, Dan worked as in the investment banking group at Advest, Inc.  He holds a B.A. from Brown University and M.B.A. from the University of Virginia.